1Lappin TR.EPO's alter ego:erythropoietin has multiple actions[J].Stem Cell,2002,20(16):485-92.
2Chikuma M,Masuda S,Kobayashi T,et al.Tissue-specific regulation of erythropoietin production in the murine kidney,brain,and uterus[J].Am J Physiol Endocrinol Metab,2000,279:1242-1248.
3Masuda S,Nagao M,Sasaki R.Erythropoietic,neurotrophic,and angiogenic functions of erythropoietin and regulation of erythropoietin production[J].International journal of hematology,1999,70:1-6.
4Fandrey J,Freds S,Ehleben W,et al.Cobalt chloride and desferrioxamine antagonize the inhibition of erythropoietin production by reactive oxygen species[J].J Kidney Int,1997,51(2):492-496.
5Cai Z,Dominador J,Wei G,et al.Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury[J].Circulation,2003,108(1):79-85.
7Cerami A,Brines ML,Ghezzi P,et al.Effects of epoetin alfa on the central nervous system[J].Semin Oncol,2001,28(2):66-70.
8Digicaylioglu M,Lipton SA.Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signaling cascades[J].Nature,2001,412:641-647.
9Joneja B,Wojchowski DM.Mitogenic signaling and inhibition of apoptosis via the erythropoietin receptor Box-1 domain[J].J Biol Chem,1997,272:11176-11184.
10Zhuang H,Niu Z,He TC,et al.Erythropoietin-dependent inhibition of apoptosis is supported by carboxyl-truncated receptor forms and blocked by dominant-negativeforms of Jak2[J].J Biol Chem,1995,270:14500-14504.
